CA2594768A1 - Synthese, production et utilisation de solvants generiques - Google Patents
Synthese, production et utilisation de solvants generiques Download PDFInfo
- Publication number
- CA2594768A1 CA2594768A1 CA002594768A CA2594768A CA2594768A1 CA 2594768 A1 CA2594768 A1 CA 2594768A1 CA 002594768 A CA002594768 A CA 002594768A CA 2594768 A CA2594768 A CA 2594768A CA 2594768 A1 CA2594768 A1 CA 2594768A1
- Authority
- CA
- Canada
- Prior art keywords
- added
- entries
- effective
- combination
- medical conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002904 solvent Substances 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title description 3
- 230000015572 biosynthetic process Effects 0.000 title description 2
- 238000003786 synthesis reaction Methods 0.000 title description 2
- 241001465754 Metazoa Species 0.000 claims description 19
- 210000001519 tissue Anatomy 0.000 claims description 11
- 206010029148 Nephrolithiasis Diseases 0.000 claims description 6
- 230000002308 calcification Effects 0.000 claims description 6
- 201000001883 cholelithiasis Diseases 0.000 claims description 6
- 208000000913 Kidney Calculi Diseases 0.000 claims description 5
- 208000001130 gallstones Diseases 0.000 claims description 5
- 230000002440 hepatic effect Effects 0.000 claims description 5
- 239000010802 sludge Substances 0.000 claims description 5
- 206010010904 Convulsion Diseases 0.000 claims description 4
- 230000036461 convulsion Effects 0.000 claims description 4
- 206010015037 epilepsy Diseases 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims description 3
- 208000006386 Bone Resorption Diseases 0.000 claims description 3
- 208000020084 Bone disease Diseases 0.000 claims description 3
- 208000001132 Osteoporosis Diseases 0.000 claims description 3
- 206010003119 arrhythmia Diseases 0.000 claims description 3
- 230000024279 bone resorption Effects 0.000 claims description 3
- 210000004087 cornea Anatomy 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 210000000653 nervous system Anatomy 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 210000004127 vitreous body Anatomy 0.000 claims description 3
- 208000003870 Drug Overdose Diseases 0.000 claims description 2
- 206010033296 Overdoses Diseases 0.000 claims description 2
- 231100000643 Substance intoxication Toxicity 0.000 claims description 2
- 206010070863 Toxicity to various agents Diseases 0.000 claims description 2
- 231100000725 drug overdose Toxicity 0.000 claims description 2
- 230000035987 intoxication Effects 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 description 17
- 229910052783 alkali metal Inorganic materials 0.000 description 10
- 150000001340 alkali metals Chemical class 0.000 description 10
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 9
- 229910001424 calcium ion Inorganic materials 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 229910001422 barium ion Inorganic materials 0.000 description 4
- XDFCIPNJCBUZJN-UHFFFAOYSA-N barium(2+) Chemical compound [Ba+2] XDFCIPNJCBUZJN-UHFFFAOYSA-N 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 229910001427 strontium ion Inorganic materials 0.000 description 4
- PWYYWQHXAPXYMF-UHFFFAOYSA-N strontium(2+) Chemical compound [Sr+2] PWYYWQHXAPXYMF-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical class [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical class CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical class [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 150000003842 bromide salts Chemical class 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229940005989 chlorate ion Drugs 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000760663 Hololena curta Mu-agatoxin-Hc1a Proteins 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229910001914 chlorine tetroxide Inorganic materials 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N dodecylbenzene Chemical class CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 210000003499 exocrine gland Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/835—Mixtures of non-ionic with cationic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/86—Mixtures of anionic, cationic, and non-ionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/02—Inorganic compounds ; Elemental compounds
- C11D3/04—Water-soluble compounds
- C11D3/046—Salts
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/02—Inorganic compounds
- C11D7/04—Water-soluble compounds
- C11D7/10—Salts
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/268—Carbohydrates or derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EG2005010036 | 2005-01-24 | ||
| EG2005010036 | 2005-01-24 | ||
| PCT/EG2006/000004 WO2006076927A2 (fr) | 2005-01-24 | 2006-01-22 | Synthese, production et utilisation de solvants generiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2594768A1 true CA2594768A1 (fr) | 2006-07-27 |
Family
ID=36692595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002594768A Abandoned CA2594768A1 (fr) | 2005-01-24 | 2006-01-22 | Synthese, production et utilisation de solvants generiques |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1851300A4 (fr) |
| JP (1) | JP2008528793A (fr) |
| KR (1) | KR20070101355A (fr) |
| CN (1) | CN101107350A (fr) |
| AP (1) | AP2007004107A0 (fr) |
| AU (1) | AU2006207750A1 (fr) |
| BR (1) | BRPI0614031A2 (fr) |
| CA (1) | CA2594768A1 (fr) |
| EA (1) | EA200701435A1 (fr) |
| IL (1) | IL184597A0 (fr) |
| MA (1) | MA29249B1 (fr) |
| MX (1) | MX2007008979A (fr) |
| NO (1) | NO20074191L (fr) |
| TN (1) | TNSN07271A1 (fr) |
| WO (1) | WO2006076927A2 (fr) |
| ZA (1) | ZA200706091B (fr) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1212394A2 (fr) * | 1999-09-02 | 2002-06-12 | The Procter & Gamble Company | Procede de desodorisation et/ou de nettoyage de moquette utilisant une composition contenant un agent desodorisant |
| JP4542279B2 (ja) * | 2001-03-30 | 2010-09-08 | 株式会社ファンケル | 洗浄用組成物 |
| JP2002322491A (ja) * | 2001-04-23 | 2002-11-08 | Fancl Corp | 洗浄用組成物 |
| JP4625595B2 (ja) * | 2001-06-06 | 2011-02-02 | 塩水港精糖株式会社 | 皮膚洗浄料 |
| US6787511B2 (en) * | 2002-08-14 | 2004-09-07 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Biphasic composition induced by polydextrose |
-
2006
- 2006-01-22 WO PCT/EG2006/000004 patent/WO2006076927A2/fr active Application Filing
- 2006-01-22 AU AU2006207750A patent/AU2006207750A1/en not_active Abandoned
- 2006-01-22 AP AP2007004107A patent/AP2007004107A0/xx unknown
- 2006-01-22 CA CA002594768A patent/CA2594768A1/fr not_active Abandoned
- 2006-01-22 BR BRPI0614031-9A patent/BRPI0614031A2/pt not_active IP Right Cessation
- 2006-01-22 EP EP06704104A patent/EP1851300A4/fr not_active Withdrawn
- 2006-01-22 MX MX2007008979A patent/MX2007008979A/es unknown
- 2006-01-22 EA EA200701435A patent/EA200701435A1/ru unknown
- 2006-01-22 KR KR1020077019496A patent/KR20070101355A/ko not_active Application Discontinuation
- 2006-01-22 CN CNA2006800030369A patent/CN101107350A/zh active Pending
- 2006-01-22 JP JP2007555455A patent/JP2008528793A/ja active Pending
-
2007
- 2007-07-12 IL IL184597A patent/IL184597A0/en unknown
- 2007-07-13 TN TNP2007000271A patent/TNSN07271A1/en unknown
- 2007-07-23 ZA ZA200706091A patent/ZA200706091B/xx unknown
- 2007-08-13 MA MA30135A patent/MA29249B1/fr unknown
- 2007-08-15 NO NO20074191A patent/NO20074191L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1851300A2 (fr) | 2007-11-07 |
| EP1851300A4 (fr) | 2010-04-14 |
| AP2007004107A0 (en) | 2007-08-31 |
| MA29249B1 (fr) | 2008-02-01 |
| IL184597A0 (en) | 2007-10-31 |
| JP2008528793A (ja) | 2008-07-31 |
| CN101107350A (zh) | 2008-01-16 |
| EA200701435A1 (ru) | 2008-10-30 |
| KR20070101355A (ko) | 2007-10-16 |
| MX2007008979A (es) | 2007-09-21 |
| TNSN07271A1 (en) | 2008-12-31 |
| NO20074191L (no) | 2007-08-15 |
| WO2006076927A2 (fr) | 2006-07-27 |
| ZA200706091B (en) | 2008-09-25 |
| BRPI0614031A2 (pt) | 2011-03-01 |
| AU2006207750A1 (en) | 2006-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1105101C (zh) | 作为基质金属蛋白质酶和TACE抑制剂的β－亚磺酰氨基异羟肟酸 | |
| WO2008041118A3 (fr) | Dérivés de pyrido[4,3-d]pyrimidin-4(3h)-one utilisés en tant qu'antagonistes du récepteur calcique | |
| AR011401A1 (es) | Composicion detergente solida alcalina | |
| ES2093266T3 (es) | Una pastilla congelada para limpieza personal hecha con una malla de entrelazamiento rigido de acido carboxilico neutralizado. | |
| Blomfield et al. | Flow rate and inorganic components of submandibular saliva in cystic fibrosis | |
| AR025761A1 (es) | Uso de alginas para combatir aguas duras, incrustaciones y problemas similares | |
| CA2594768A1 (fr) | Synthese, production et utilisation de solvants generiques | |
| Coe et al. | Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation | |
| ES2008598A6 (es) | Composicion limpiadora acuosa espesada reforzada sin fosfatos o con bajo contenido de fosfatos. | |
| EP1347986B1 (fr) | Sels metalliques de sulfate de glucosamine cristallin et processus de preparation de ces sels | |
| BR0114251A (pt) | Carbonato de sódio granulado obtido através de granulação por pulverização em leito fluido e um processo para sua produção | |
| CN1804046A (zh) | 钢渣脱离剂 | |
| AU2002217416A1 (en) | Crystalline glucosamine sulphate metal salts | |
| GR3030625T3 (en) | New salts of 2- (2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations | |
| WO2020112063A1 (fr) | Solution nasale à caractéristique d'eau de source naturelle de bassin fermé et procédé d'obtention de ladite solution nasale | |
| CN104586879A (zh) | 一种治疗骨关节疾病的药物及其制备方法 | |
| BE900498A (fr) | Procede et comprime pour le traitement hygienique des cabinets d'aisances. | |
| CN101993230A (zh) | 一种喷煤管预制件配方 | |
| EP1228762A3 (fr) | Méthode de préparation du pamidronate de disodium | |
| Pontonnier et al. | Etude des systems MeI2BeF4 Na2BeF4 | |
| RU2011123762A (ru) | Фармацевтическая композиция, содержащая ибупрофен, псевдоэфедрин и хлорфенирамин | |
| RU2238735C1 (ru) | Средство для литолиза мочевых камней и способ его получения | |
| Toth et al. | Calcinosis circumscripta in the antebrachiocarpal joint of a horse | |
| SU1676624A1 (ru) | Состав дл пломбировани передних зубов | |
| Bandini | Iperparatiroidismo, Calciomimetici e Trapianto renale |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |